Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
15.42
+0.02 (0.13%)
Aug 4, 2025, 4:00 PM - Market closed

Company Description

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.

The company’s flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system.

It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body.

In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data.

It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems.

The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008.

Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Tandem Diabetes Care, Inc.
Tandem Diabetes Care logo
CountryUnited States
Founded2006
IPO DateNov 14, 2013
IndustryMedical Devices
SectorHealthcare
Employees2,650
CEOJohn Sheridan

Contact Details

Address:
12400 High Bluff Drive
San Diego, California 92130
United States
Phone858 366 6900
Websitetandemdiabetes.com

Stock Details

Ticker SymbolTNDM
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001438133
CUSIP Number875372203
ISIN NumberUS8753722037
Employer ID20-4327508
SIC Code3841

Key Executives

NamePosition
John F. SheridanPresident, Chief Executive Officer and Director
Leigh A. VossellerExecutive Vice President, Chief Financial Officer and Treasurer
Jean-Claude E. KyrillosExecutive Vice President and Chief Operating Officer
Susan M. MorrisonExecutive Vice President and Chief Administrative Officer
Elizabeth Anne GasserExecutive Vice President and Chief Strategy and Product Officer
Mark NovaraExecutive Vice President and Chief Commercial Officer
Rick A. CarpenterChief Technical Officer
Shannon M. Hansen J.D.Executive Vice President, Chief Legal, Privacy and Compliance Officer and Secretary
Tom FoxChief Human Resources Officer
Dr. Jordan Pinsker M.D.Chief Medical Officer

Latest SEC Filings

DateTypeTitle
May 29, 2025SDForm - SD
May 23, 20258-KCurrent Report
May 20, 20258-KCurrent Report
May 15, 2025SCHEDULE 13GFiling
May 12, 20258-KCurrent Report
Apr 30, 202510-QQuarterly Report
Apr 30, 20258-KCurrent Report
Apr 29, 2025SCHEDULE 13G/AFiling
Apr 8, 2025ARSFiling
Apr 8, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material